Beijing Inno Medicine Co., Ltd.
7 clinical trials · Sponsor
◉ Watch Beijing Inno Medicine Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis (NCT07521007) | Beijing Inno Medicine Co., Ltd. | 2026-07-31 |
| YN001-004 in Patients With Coronary Atherosclerosis in Australia (NCT06700720) | Beijing Inno Medicine Co., Ltd. | 2026-02-01 |
| Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction (NCT07311330) | Beijing Inno Medicine Co., Ltd. | 2026-01-31 |
| Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects (NCT07309042) | Beijing Inno Medicine Co., Ltd. | 2025-12-01 |
| A Pharmacokinetic Study of YN001 in Healthy Participants (NCT07190885) | Beijing Inno Medicine Co., Ltd. | 2025-11-18 |
| YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis (NCT06048588) | Beijing Inno Medicine Co., Ltd. | 2023-10-08 |
| A First-in-human Study of YN001 in Healthy Volunteers (NCT05635084) | Beijing Inno Medicine Co., Ltd. | 2022-12-16 |
Track Beijing Inno Medicine Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.